BiomedicInsure presents a unique insurance solution against the consequences of safety failings in healthcare products

The Verlingue Life Sciences division this week organised a conference in Paris to present an insurance solution for life science professionals.


Given the general increase in the safety requirements for healthcare products, all industrialists in the sector are likely to be confronted with:


– very significant losses generated by batch recall campaigns that are more and more frequent and publicised. A large number of the consequences of these recalls (cost of the product / loss of margin / crisis management / rehabilitating brand image) are not insured under solutions currently available on the market.


new ways of being held liable, due to the recent introduction of class actions in France.


BiomedicInsure has developed an innovative insurance solution that provides health product manufacturers with cover and support in the protection of their assets.


The conference, organised in partnership with AMLIS (Association of Mid-Size Healthcare Laboratories and Industries) on March 30, was the opportunity for visitors to discover this solution and engage in discussions with BiomedicInsure experts and a lawyer from the firm De Gaulle Fleurance & Associates.